Back to search

Article

Targeting the ITGA3B1 Complex with A Novel Antibody-Drug Conjugate for Metastatic Bladder Cancer

2025-04-07

Abstract excerpt

Advances in antibody (Ab) phage display technologies have enabled the development of targeted therapies with enhanced precision and clinical efficacy. Here, we report a phenotypic screening strategy combining target-unbiased live-cell biopanning with in situ chemical crosslinking and mass spectrometry to identify internalizing antibodies and their cognate antigens—key features for effective antibody-drug conjugate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4b71db79-28a8-5b7c-a142-e15a3ec6c961
DOI
10.1101/2025.04.06.647354
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting the ITGA3B1 Complex with A Novel Antibody-Drug Conjugate for Metastatic Bladder CancerDOI 10.1101/2025.04.06.647354
Select a neighboring publication to make it the new centre.